S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Buy THIS stock before Taiwan is attacked (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
Buy THIS stock before Taiwan is attacked (Ad)
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
Open vs. Anonymous Employee Feedback — Which is Better?
Buy THIS stock before Taiwan is attacked (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Buy THIS stock before Taiwan is attacked (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
Buy THIS stock before Taiwan is attacked (Ad)
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
Open vs. Anonymous Employee Feedback — Which is Better?
Buy THIS stock before Taiwan is attacked (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Buy THIS stock before Taiwan is attacked (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
Buy THIS stock before Taiwan is attacked (Ad)
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
Open vs. Anonymous Employee Feedback — Which is Better?
Buy THIS stock before Taiwan is attacked (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Buy THIS stock before Taiwan is attacked (Ad)
10 Ways Entrepreneurs Can Navigate a Down Economy
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
Buy THIS stock before Taiwan is attacked (Ad)
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
Open vs. Anonymous Employee Feedback — Which is Better?
Buy THIS stock before Taiwan is attacked (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
NYSE:OGN

Organon & Co. (OGN) Price Target & Analyst Ratings

$19.54
-0.32 (-1.61%)
(As of 05/26/2023 07:00 PM ET)
Compare
Today's Range
$19.43
▼
$20.09
50-Day Range
$19.54
▼
$24.63
52-Week Range
$19.15
▼
$38.95
Volume
2.01 million shs
Average Volume
2.12 million shs
Market Capitalization
$4.98 billion
P/E Ratio
6.69
Dividend Yield
5.73%
Price Target
$29.00
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Organon & Co. Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 4 Analyst Ratings

Consensus Analyst Price Target

$29.00
48.41% Upside
High Prediction$34.00
Average Prediction$29.00
Low Prediction$24.00
TypeCurrent
5/29/22 to 5/29/23		1 Month Ago
4/29/22 to 4/29/23		3 Months Ago
2/28/22 to 2/28/23		1 Year Ago
5/29/21 to 5/29/22
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
5 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
4 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$29.00$29.00$30.75$40.25
Predicted Upside48.41% Upside16.08% Upside11.75% Upside20.84% Upside
Get Organon & Co. Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OGN and its competitors with MarketBeat's FREE daily newsletter.


OGN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OGN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Organon & Co. Stock vs. The Competition

TypeOrganon & Co.Medical CompaniesS&P 500
Consensus Rating Score
2.25
2.66
2.48
Consensus RatingHoldBuyHold
Predicted Upside48.41% Upside1,318.25% Upside196.76% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/15/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Initiated CoverageOutperform$33.00+53.35%
11/4/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetEqual Weight$27.00 ➝ $24.00-7.26%
10/14/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 DowngradeNeutral ➝ Underperform$25.00+4.04%
9/6/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 UpgradeNeutral ➝ Overweight$37.00 ➝ $34.00+19.30%
(Data available from 5/29/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












OGN Price Target - Frequently Asked Questions

What is Organon & Co.'s consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for Organon & Co. stock is Hold based on the current 1 sell rating, 1 hold rating and 2 buy ratings for OGN. The average twelve-month price prediction for Organon & Co. is $29.00 with a high price target of $34.00 and a low price target of $24.00. Learn more on OGN's analyst rating history.

Do Wall Street analysts like Organon & Co. more than its competitors?

Analysts like Organon & Co. less than other Medical companies. The consensus rating for Organon & Co. is Hold while the average consensus rating for medical companies is Buy. Learn more on how OGN compares to other companies.

Does Organon & Co.'s stock price have much upside?

According to analysts, Organon & Co.'s stock has a predicted upside of 16.08% based on their 12-month price targets.

What analysts cover Organon & Co.?

Organon & Co. has been rated by Raymond James in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NYSE:OGN) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -